excessive scarring hypertrophic scarring
Conditions
Interventions
The laser treatment that will be assessed in this study will be used at the end
of the surgical operation only, directly after closure of the surgical wound.
Breast reduction surgery is performed ex
Monocryl® 3.0 subcutaneously and Monocryl® 4.0
intra-cutaneously. After closure a part of the surgical wounds at the underside
of both breasts (left and right) will be treated with the EkkyLiteTM la
Sponsors
Vrije Universiteit Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Patients undergoing breast reduction surgery with a wise pattern technique. - Older than 18 years of age. - Willing to participate.
Exclusion criteria
Exclusion criteria: - Dark skin (skin types V or VI, Fitzpatrick Skin Typing Test) - Pregnant woman - Malignant tumor skin disease - Bacterial or viral infectious skin disease - Immunosuppression (linked to a pathology or specific treatment) - BMI > 27 - Hart and/or lung disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcomes of the Vancouver Scar Scale (VSS) and POSAS score at 12 months after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective scar measures: volume (3D), width, height, colour. Cosmetic appearance. The patient will rate the scar*s overall cosmetic aspect on a visual analogue scale. Two independent plastics surgeons will rate the overall aspect as well on basis of the photographs. Complications. Time course of scar formation using all parameter measures at earlier time points (10 days, 6 weeks, 3 and 6 months after surgery). | — |
Countries
Netherlands
Outcome results
None listed